# UCB Stem Cells for Autism Spectrum Disorders

> **NCT04710810** · PHASE1 · COMPLETED · sponsor: **St. Petersburg Bekhterev Research Psychoneurological Institute** · enrollment: 30 (actual)

## Conditions studied

- Autism Spectrum Disorder

## Interventions

- **OTHER:** umbilical cord blood mononuclear stem cells

## Key facts

- **NCT ID:** NCT04710810
- **Lead sponsor:** St. Petersburg Bekhterev Research Psychoneurological Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-04
- **Primary completion:** 2021-01-31
- **Final completion:** 2021-07-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04710810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04710810, "UCB Stem Cells for Autism Spectrum Disorders". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04710810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*